EIGR logo

Eiger BioPharmaceuticals (EIGR) Net Income

Annual Net Income

-$74.96 M
+$21.81 M+22.54%

December 31, 2023

Summary

Performance

1-Year Change

+22.54%

3-Year Change

-15.24%

5-Year Change

-43.08%

15-Year Change

-76.6%

EIGR Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

27.68%
EIGR annual net profit is higher than 27.68% of companies in Healthcare sector

High & Low

All-time High

-$2.86 M

3-Year Low

-$96.78 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
EIGR previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
EIGR next annual earnings announcement has not yet been scheduled

OtherEIGRprofitabilitymetrics:

Annual Net Margin

-
EIGR annual net profit margin value is unknown

Annual Revenue

$15.77 M
EIGR annual revenue is $15.77 million

Annual Gross Profit

$15.75 M
EIGR annual gross profit is $15.75 million

Annual EPS

-$50.78
EIGR annual earnings per share is -$50.78

Quarterly Net Income

-$13.45 M
+$4.58 M+25.38%

December 31, 2023

Summary

Performance

3-Month Change

+25.38%

1-Year Change

+46.48%

3-Year Change

+28.46%

5-Year Change

+18.47%

EIGR Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

34.7%
EIGR quarterly net profit is higher than 34.7% of companies in Healthcare sector

High & Low

All-time High

$29.25 M
EIGR quarterly net profit is currently -146.00% below its historical high of $29.25 million

3-Year Low

-$27.11 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2023
EIGR previous earnings announcement was published on Dec 31, 2023

Next Quarterly Earnings Report Date

N/A
EIGR next earnings announcement has not yet been scheduled

OtherEIGRprofitabilitymetrics:

Quarterly Net Margin

-
EIGR quarterly net profit margin value is unknown

Quarterly Revenue

$3.80 M
EIGR quarterly revenue is $3.80 million

Quarterly Gross Profit

$3.70 M
EIGR quarterly gross profit is $3.70 million

Quarterly EPS

-
EIGR quarterly earnings per share value is unknown

TTM Net Income

-$74.96 M
+$11.68 M+13.48%

December 31, 2023

Summary

Performance

3-Month Change

+13.48%

1-Year Change

+22.54%

3-Year Change

-15.24%

5-Year Change

-6.71%

EIGR TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

28.16%
EIGR TTM net profit is higher than 28.16% of companies in Healthcare sector

High & Low

All-time High

-$3.00 M

3-Year Low

-$96.92 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2023
EIGR previous earnings announcement was published on Dec 31, 2023

Next Quarterly Earnings Report Date

N/A
EIGR next earnings announcement has not yet been scheduled

OtherEIGRprofitabilitymetrics:

Annual Net Margin

-
EIGR annual net profit margin value is unknown

TTM Revenue

$15.77 M
EIGR TTM revenue is $15.77 million

TTM Gross Profit

$15.75 M
EIGR TTM gross profit is $15.75 million

TTM EPS

-
EIGR TTM earnings per share value is unknown

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$74.96 M
EIGR annual net profit is -$74.96 million

Annual Revenue

$15.77 M
EIGR annual revenue is $15.77 million

Annual Cost Of Goods Sold

$24.00 K
EIGR annual cost of goods sold is $24.00 thousand

Annual Operating Expenses

$87.53 M
EIGR annual total operating expenses is $87.53 million

Annual Interest Expense

$5.47 M
EIGR annual interest expense is $5.47 million

Annual Income Tax

$6000.00
EIGR annual income tax is $6000.00

EIGR Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+22.5%+46.5%+22.5%
3 y3 years-15.2%+28.5%-15.2%
5 y5 years-43.1%+18.5%-6.7%

EIGR Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-121.0%+22.5%at high+50.4%-121.0%+22.6%
5 y5-year-121.0%+22.5%-146.0%+50.4%-264.5%+22.6%
alltimeall time-2520.2%+22.5%-146.0%+50.4%-2398.8%+22.6%

Eiger BioPharmaceuticals Net Income History

DateAnnualQuarterlyTTM
Dec 2023
-$74.96 M(-22.5%)
-$13.45 M(-25.4%)
-$74.96 M(-13.5%)
Sep 2023
-
-$18.03 M(-12.9%)
-$86.65 M(-9.5%)
Jun 2023
-
-$20.70 M(-9.2%)
-$95.73 M(-1.2%)
Mar 2023
-
-$22.78 M(-9.4%)
-$96.92 M(+0.1%)
Dec 2022
-$96.78 M(+185.3%)
-$25.14 M(-7.3%)
-$96.78 M(+3.6%)
Sep 2022
-
-$27.11 M(+23.9%)
-$93.41 M(+5.5%)
Jun 2022
-
-$21.88 M(-3.4%)
-$88.52 M(+3.2%)
Mar 2022
-
-$22.64 M(+4.0%)
-$85.81 M(+153.0%)
Dec 2021
-$33.92 M(-47.9%)
-$21.77 M(-2.0%)
-$33.92 M(+9.6%)
Sep 2021
-
-$22.22 M(+15.9%)
-$30.95 M(+26.8%)
Jun 2021
-
-$19.17 M(-165.6%)
-$24.41 M(+18.7%)
Mar 2021
-
$29.25 M(-255.5%)
-$20.56 M(-68.4%)
Dec 2020
-$65.05 M(-7.4%)
-$18.81 M(+19.9%)
-$65.05 M(+3.0%)
Sep 2020
-
-$15.68 M(+2.3%)
-$63.16 M(-4.4%)
Jun 2020
-
-$15.33 M(+0.6%)
-$66.10 M(-3.2%)
Mar 2020
-
-$15.24 M(-9.9%)
-$68.30 M(-2.8%)
Dec 2019
-$70.25 M(+34.1%)
-$16.92 M(-9.1%)
-$70.25 M(+0.6%)
Sep 2019
-
-$18.62 M(+6.2%)
-$69.83 M(+2.2%)
Jun 2019
-
-$17.53 M(+2.0%)
-$68.36 M(+12.5%)
Mar 2019
-
-$17.19 M(+4.2%)
-$60.75 M(+16.0%)
Dec 2018
-$52.39 M
-$16.50 M(-3.8%)
-$52.39 M(+12.0%)
Sep 2018
-
-$17.14 M(+72.9%)
-$46.78 M(+20.5%)
Jun 2018
-
-$9.91 M(+12.3%)
-$38.81 M(-3.1%)
DateAnnualQuarterlyTTM
Mar 2018
-
-$8.83 M(-18.9%)
-$40.04 M(-5.7%)
Dec 2017
-$42.45 M(-9.9%)
-$10.89 M(+18.8%)
-$42.45 M(-4.2%)
Sep 2017
-
-$9.17 M(-17.7%)
-$44.32 M(-4.7%)
Jun 2017
-
-$11.15 M(-0.8%)
-$46.52 M(-4.2%)
Mar 2017
-
-$11.24 M(-12.0%)
-$48.58 M(+3.2%)
Dec 2016
-$47.09 M(+253.5%)
-$12.77 M(+12.3%)
-$47.09 M(+490.5%)
Sep 2016
-
-$11.37 M(-13.9%)
-$7.97 M(+165.8%)
Jun 2016
-
-$13.20 M(+35.4%)
-$3.00 M(-52.6%)
Mar 2016
-
-$9.75 M(-137.0%)
-$6.32 M(-52.5%)
Dec 2015
-$13.32 M(-60.6%)
$26.34 M(-511.9%)
-$13.32 M(-73.9%)
Sep 2015
-
-$6.40 M(-61.3%)
-$51.01 M(-3.7%)
Jun 2015
-
-$16.52 M(-1.3%)
-$52.97 M(+21.9%)
Mar 2015
-
-$16.75 M(+47.7%)
-$43.44 M(+28.3%)
Dec 2014
-$33.85 M(+69.3%)
-$11.34 M(+35.7%)
-$33.85 M(+18.0%)
Sep 2014
-
-$8.36 M(+19.5%)
-$28.69 M(+11.3%)
Jun 2014
-
-$6.99 M(-2.4%)
-$25.79 M(+8.9%)
Mar 2014
-
-$7.16 M(+15.9%)
-$23.69 M(+18.5%)
Dec 2013
-$20.00 M(+27.2%)
-$6.18 M(+13.3%)
-$20.00 M(+44.7%)
Sep 2013
-
-$5.45 M(+11.4%)
-$13.82 M(+65.2%)
Jun 2013
-
-$4.89 M(+41.1%)
-$8.36 M(+141.1%)
Mar 2013
-
-$3.47 M
-$3.47 M
Dec 2012
-$15.72 M(+449.4%)
-
-
Dec 2011
-$2.86 M(-59.1%)
-
-
Jun 2011
-$6.99 M
-
-

FAQ

  • What is Eiger BioPharmaceuticals annual net profit?
  • What is the all time high annual net income for Eiger BioPharmaceuticals?
  • What is Eiger BioPharmaceuticals annual net income year-on-year change?
  • What is Eiger BioPharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for Eiger BioPharmaceuticals?
  • What is Eiger BioPharmaceuticals quarterly net income year-on-year change?
  • What is Eiger BioPharmaceuticals TTM net profit?
  • What is the all time high TTM net income for Eiger BioPharmaceuticals?
  • What is Eiger BioPharmaceuticals TTM net income year-on-year change?

What is Eiger BioPharmaceuticals annual net profit?

The current annual net income of EIGR is -$74.96 M

What is the all time high annual net income for Eiger BioPharmaceuticals?

Eiger BioPharmaceuticals all-time high annual net profit is -$2.86 M

What is Eiger BioPharmaceuticals annual net income year-on-year change?

Over the past year, EIGR annual net profit has changed by +$21.81 M (+22.54%)

What is Eiger BioPharmaceuticals quarterly net profit?

The current quarterly net income of EIGR is -$13.45 M

What is the all time high quarterly net income for Eiger BioPharmaceuticals?

Eiger BioPharmaceuticals all-time high quarterly net profit is $29.25 M

What is Eiger BioPharmaceuticals quarterly net income year-on-year change?

Over the past year, EIGR quarterly net profit has changed by +$11.68 M (+46.48%)

What is Eiger BioPharmaceuticals TTM net profit?

The current TTM net income of EIGR is -$74.96 M

What is the all time high TTM net income for Eiger BioPharmaceuticals?

Eiger BioPharmaceuticals all-time high TTM net profit is -$3.00 M

What is Eiger BioPharmaceuticals TTM net income year-on-year change?

Over the past year, EIGR TTM net profit has changed by +$21.81 M (+22.54%)